drugset / Trial / NCT00148447
The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of this study is to evaluate the therapeutic effect of escitalopram in the treatment of negative symptoms in schizophrenia patients in a double-blind placebo-controlled study.
Timeline
- Start
- 2004-11
- Primary completion
- —
- Completion
- 2005-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Escitalopram | Small molecule | — | — |